Study Stopped
Decision of investigational team
Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant
iUni
A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2 Unicompartmental Knee Resurfacing Device
1 other identifier
observational
120
1 country
8
Brief Summary
Study is prospective and multi-center. Study will include 100 to 200 patients across up to 20 sites.The study sites will be located in the United States.The study objective is to evaluate the safety and performance of the ConforMIS iUni® Unicompartmental Knee Resurfacing Device in patients with single compartment osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2010
Longer than P75 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 4, 2010
CompletedFirst Posted
Study publicly available on registry
May 5, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2023
CompletedOctober 25, 2023
October 1, 2023
4.6 years
May 4, 2010
October 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Knee Society Score
to assess knee pain and function
2 years
WOMAC Osteoarthritis Index
to assess knee pain and function
2 years
Secondary Outcomes (5)
Knee Society Score and WOMAC at years 5 and 10 post-implantation
10 years
Annual revision rates at years 1 through 10 post-implantation
10 years
Incidence of major procedure-related and device-related complications
10 years
Length of tourniquet time in minutes
6 weeks
Length of hospital stay in hours
6 weeks
Study Arms (1)
open label
iUni® Unicompartmental Knee Resurfacing Device
Interventions
The iUni® Unicompartmental Resurfacing Device is an FDA cleared and CE Marked implant designed for patients with damage isolated to either the medial or lateral tibiofemoral compartment of the knee. The patient-specific iUni is designed from a CT scan of an individual patient's knee using a design process which interactively maps the diseased area and defines the extent of misalignment present in the knee. This process allows definition of the shape and size of the femoral and tibial components of the implant, as well as the disposable instrumentation
Eligibility Criteria
Patients over 18 who have uni-compartmental osteoarthritis to be treated with a unilateral knee resurfacing procedure
You may qualify if:
- Clinical condition included in the approved Indications For Use
- Unicompartmental osteoarthritis of the medial or lateral tibiofemoral compartment
- Willingness to participate in the clinical study, to give informed consent and to attend all follow-up visits
- \> 18 years of age
You may not qualify if:
- Simultaneous bilateral procedure required
- BMI \> 35
- Treatment for cancer within the past 5 years, with the exception of skin cancer
- Poorly controlled diabetes
- Neuromuscular conditions which prevent patient from participating in study activities
- Active local or systemic infection
- Immunocompromised
- Fibromyalgia or other general body pain related condition
- Advanced tricompartmental osteoarthritis
- Symptomatic patellofemoral disease
- Rheumatoid arthritis or other forms of inflammatory joint disease
- Loss of bone or musculature, osteoporosis, osteonecrosis, neuromuscular or vascular compromise in the area of the joint to be operated to an extent that the procedure is unjustified
- Advanced loss of osteochondral structure on the affected femoral condyle
- Compromised ACL, PCL or collateral ligament
- Severe (\>15º) fixed valgus or varus deformity
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Restor3Dlead
Study Sites (8)
Arkansas Specialty Orthopaedics & HipKneeArkansas Foundation for the Facility
Little Rock, Arkansas, 72205, United States
S.T.A.R. Orthopaedics
La Quinta, California, 92253, United States
Center for the Knee and Shoulder
Monterey, California, 93940, United States
JFK Medical Center
Atlantis, Florida, 33462, United States
Heekin Clinic
Jacksonville, Florida, 32204, United States
Great Lakes Bone and Joint
Battle Creek, Michigan, 49015, United States
Orthopedic Associates of Pittsburgh
Monroeville, Pennsylvania, 15146, United States
Advanced Orthopedics and Sports Medicine
Cypress, Texas, 77429, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
C. Lowry Barnes, M.D
Hip Knee Arkansas Foundation
- STUDY DIRECTOR
Marc Quartulli
Restor3D
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2010
First Posted
May 5, 2010
Study Start
April 1, 2010
Primary Completion
October 30, 2014
Study Completion
January 10, 2023
Last Updated
October 25, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share